Fine Organic Industries Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹15,796 Cr
- P/E
- 36.06
- ROE
- 16.46%
- PEG
- -2.80
- Price to sales
- 6.38
- Debt to equity
- 0.03
- 52W high / low
- ₹5,626 / ₹3,887
- Sales growth (5Y)
- 15.86%
- EBITDA margin
- 21.48%
- Net profit margin
- 17.26%
- Promoter holding
- 75.00%
- Sales (last year)
- ₹2,472 Cr
Fine Organic Industries is engaged in and outside India as manufacturers, processors, suppliers, distributors, dealers, importers, exporters of wide range of oleochemical-based additives used in foods, plastics, cosmetics, coatings and other specialty application in various industries.
Guidance scorecard · Q1 FY27 call
What Fine Organic's management guided
and where it ranks in Chemicals & Petrochemicals
Chemicals & Petrochemicals
RevenueQ4 FY26 call
0–10%- Growth expected to be flat for FY'27 and FY'28 due to current plants running at full capacity; no meaningful volume growth until new capacities come online.
- Post-FY'28, growth anticipated to resume once SEZ plant and U.S. plant are commissioned, enabling incremental volume sales.
- Any top-line growth before then likely to come from price increases rather than volume expansion.
- Historical pattern shows phases of capex followed by 1-2 years of strong growth, then flat growth until capacities are fully utilized.
- Recent delays in land acquisition for new SEZ plant caused growth postponement; new plant capacity expected to unlock further growth.
2 more points from Fine Organic's call on revenue
Create a free account to keep reading this call
MarginsQ4 FY26 call
FlatSee what Fine Organic said on margins — free account, 30 seconds.
CapexQ4 FY26 call
Planned- Thailand and Malaysia expansions planned but delayed due to SEZ focus.
FundraisingQ4 FY26 call
See what Fine Organic said on fundraising — free account, 30 seconds.
Order bookQ4 FY26 call
- The company is currently cautious with customer contracts due to raw material price inflation and geopolitical uncertainties.
- Most contracts are short-term (1-3 months), with customers being cooperative given the unstable situation.
- New contracts are mostly short-term to manage volatility.
- Demand remains stable, and domestic customers receive priority supply in case of capacity constraints.
2 more points from Fine Organic's call on the order book
Create a free account to keep reading this call
Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹263 Cr | 3.4 | |
| 2 | 40%+ | Flat | ₹4,375 Cr | 83.7 | |
| 3 | 40%+ | Flat | ₹3,259 Cr | 4.0 | |
| 4 | 40%+ | Flat | ₹145 Cr | 15.9 | |
| 5 | 20–40% | Up 2%+ | ₹1.81L Cr | 90.9 | |
| 6 | 20–40% | Up 2%+ | ₹48,366 Cr | 78.3 |
Sign up free to see every company in the sector ranking and track Fine Organic.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Fine Organic
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Fine Organic
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 597 | 547 | 540 | 488 | 547 | 550 | 596 | 517 | 607 | 588 | 597 | 555 | 625 |
| Expenses + | 395 | 407 | 410 | 371 | 403 | 410 | 446 | 414 | 487 | 466 | 463 | 461 | 496 |
| Operating Profit | 202 | 140 | 130 | 117 | 144 | 139 | 150 | 103 | 120 | 123 | 134 | 94 | 129 |
| OPM % | 34% | 26% | 24% | 24% | 26% | 25% | 25% | 20% | 20% | 21% | 22% | 17% | 21% |
| Other Income + | 13 | 14 | 17 | 17 | 22 | 24 | 22 | 25 | 26 | 47 | 21 | 21 | 35 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 |
| Depreciation | 13 | 12 | 14 | 15 | 15 | 12 | 13 | 13 | 15 | 12 | 13 | 14 | 18 |
| Profit before tax | 201 | 143 | 132 | 119 | 150 | 151 | 159 | 115 | 130 | 157 | 142 | 101 | 143 |
| Tax % | 26% | 30% | 22% | 21% | 24% | 25% | 26% | 28% | 25% | 26% | 24% | 27% | 18% |
| Net Profit + | 149 | 100 | 103 | 94 | 115 | 113 | 117 | 83 | 97 | 117 | 109 | 74 | 117 |
| EPS in Rs | 48.74 | 32.54 | 33.71 | 30.73 | 37.36 | 36.94 | 38.30 | 26.97 | 31.68 | 38.19 | 35.40 | 24.11 | 38.32 |
Financials of Fine Organic
Profit & Loss
Annual income statement trend
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 660 | 778 | 856 | 1,060 | 1,038 | 1,133 | 1,876 | 3,023 | 2,123 | 2,269 | 2,366 |
| Expenses + | 514 | 633 | 697 | 827 | 803 | 935 | 1,513 | 2,194 | 1,591 | 1,757 | 1,886 |
| Operating Profit | 146 | 145 | 158 | 234 | 235 | 198 | 363 | 829 | 532 | 512 | 480 |
| OPM % | 22% | 19% | 19% | 22% | 23% | 17% | 19% | 27% | 25% | 23% | 20% |
| Other Income + | 8 | 4 | 16 | 20 | 20 | 17 | 33 | 64 | 71 | 98 | 124 |
| Interest | 7 | 4 | 3 | 2 | 5 | 6 | 5 | 5 | 2 | 2 | 4 |
| Depreciation | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 56 |
| Profit before tax | 117 | 121 | 151 | 234 | 216 | 162 | 352 | 841 | 544 | 555 | 543 |
| Tax % | 35% | 36% | 37% | 40% | 24% | 26% | 26% | 26% | 24% | 26% | 23% |
| Net Profit + | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 417 |
| EPS in Rs | 157.74 | 161.22 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 201.60 | 134.34 | 133.89 | 136.03 |
| Dividend Payout % | 29% | 9% | 23% | 16% | 13% | 28% | 11% | 4% | 7% | 8% | 8% |
Financials of Fine Organic
Balance Sheet
Capital structure and asset base
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 249 | 323 | 380 | 485 | 604 | 716 | 944 | 1,526 | 1,906 | 2,280 | 2,649 |
| Borrowings + | 102 | 40 | 54 | 128 | 125 | 89 | 59 | 29 | 4 | 3 | 68 |
| Other Liabilities + | 63 | 76 | 81 | 74 | 108 | 127 | 219 | 237 | 182 | 213 | 266 |
| Total Liabilities | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,999 |
| Fixed Assets + | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 | 390 |
| CWIP | 6 | 3 | 32 | 106 | 6 | 26 | 14 | 40 | 30 | 27 | 62 |
| Investments | 0 | 11 | 11 | 10 | 33 | 31 | 31 | 39 | 36 | 35 | 38 |
| Other Assets + | 289 | 334 | 399 | 508 | 597 | 694 | 962 | 1,513 | 1,774 | 2,085 | 2,508 |
| Total Assets | 419 | 445 | 530 | 702 | 852 | 948 | 1,236 | 1,807 | 2,108 | 2,511 | 2,999 |
Financials of Fine Organic
Cash Flows
Operating, investing and financing cash movement
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 45 | 65 | 98 | 219 | 134 | 67 | 485 | 635 | 204 | 430 | |
| Cash from Investing Activity + | -16 | -52 | -93 | -85 | -40 | -32 | -128 | -396 | -676 | -409 | |
| Cash from Financing Activity + | -55 | -17 | 92 | -37 | -41 | -68 | -69 | -59 | -34 | -0 | |
| Net Cash Flow | -26 | -3 | 97 | 98 | 53 | -33 | 289 | 180 | -506 | 20 | |
| Free Cash Flow | 34 | 13 | 5 | 146 | 88 | 6 | 405 | 549 | 77 | 288 | |
| CFO/OP | 65% | 73% | 79% | 119% | 89% | 41% | 86% | 148% | 68% | 117% |
Financials of Fine Organic
Ratios
Working capital efficiency and return ratios
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 49 | 52 | 62 | 54 | 47 | 52 | 59 | 42 | 54 | 53 | 54 |
| Inventory Days | 72 | 68 | 58 | 50 | 79 | 63 | 72 | 91 | 78 | 100 | 104 |
| Days Payable | 50 | 47 | 46 | 30 | 51 | 49 | 47 | 36 | 41 | 43 | 45 |
| Cash Conversion Cycle | 71 | 72 | 75 | 74 | 74 | 66 | 84 | 97 | 91 | 110 | 113 |
| Working Capital Days | 80 | 69 | 80 | 76 | 63 | 65 | 79 | 76 | 77 | 104 | 92 |
| ROCE % | 35% | 38% | 44% | 32% | 22% | 39% | 65% | 31% | 26% | 21% |
Guidance history
How Fine Organic's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q4 FY26 call → | 0–10% | Flat | Planned | — | — |
| Q3 FY26 call → | 0–10% | Flat | Planned | — | — |
| Q4 FY25 call → | 10–20% | Flat | Planned | Planned | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
35 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +14.9% | 71% |
| Last 6 months | +11.3% | 68% |
| Last 3 months | +5.6% | 73% |
The price is 27.3% below its all-time high of ₹7,087.75 (23 Sept 2022). Stocks more than 20% below their peak have their score halved, so 70 became 35.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Fine Organic: 0.4 × 71 + 0.4 × 68 + 0.2 × 73 = 70, halved to 35 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Fine Organic's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
- Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
- NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
